The Wall Street Journal reports on research out of the Johns Hopkins University Kimmel Cancer Center that describes a new blood test which can decipher a patient’s genetic fingerprint in search of known DNA biomarkers for cancer based on the sequences of several tumor types. According to the WSJ, the researchers said that the cost of their DNA test ― currently about $5,000 ― would soon by comparable to that of a CT scan ― approximately $1,500 ― and that it could be ready for use within two years.